Privileged fragment-based design, synthesis and in vitro antitumor activity of imatinib analogues.
Turk J Chem
; 47(2): 426-435, 2023.
Article
in En
| MEDLINE
| ID: mdl-37528931
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Turk J Chem
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Turquía